Literature DB >> 9228783

Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase.

G Arlet1, M Rouveau, A Philippon.   

Abstract

SHV-6 was previously identified by its susceptibility pattern and biochemical criteria in a clinical isolate of Klebsiella pneumoniae which was resistant to ceftazidime. It contains only a single point difference with the beta laSHV-1 gene as determined by PCR amplification and nucleotide sequencing. This is the result of a single amino acid substitution, Ala for Asp, at position 179. Directed mutagenesis experiments have shown this substitution to confer selective resistance to ceftazidime in the TEM family.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228783     DOI: 10.1016/s0378-1097(97)00196-1

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  40 in total

1.  Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes.

Authors:  P A Bradford
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  A new SHV-derived extended-spectrum beta-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the -loop.

Authors:  H Kurokawa; T Yagi; N Shibata; K Shibayama; K Kamachi; Y Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR.

Authors:  A Chanawong; F H M'Zali; J Heritage; A Lulitanond; P M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams.

Authors:  C C Randegger; A Keller; M Irla; A Wada; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum beta-lactamase gene and a class 1 integron.

Authors:  L Villa; C Pezzella; F Tosini; P Visca; A Petrucca; A Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  Novel plasmid-encoded class C beta-lactamase (MOX-2) in Klebsiella pneumoniae from Greece.

Authors:  Laurent Raskine; Isabelle Borrel; Guilène Barnaud; Sophie Boyer; Béatrice Hanau-Berçot; Jérome Gravisse; Roger Labia; Guillaume Arlet; Marie-José Sanson-Le-Pors
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

7.  Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria.

Authors:  I E Aibinu; V C Ohaegbulam; E A Adenipekun; F T Ogunsola; T O Odugbemi; B J Mee
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants.

Authors:  Aurora García-Fernández; Laura Villa; Claudio Carta; Carolina Venditti; Alessandra Giordano; Mario Venditti; Carlo Mancini; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

9.  Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia.

Authors:  Olfa Bouallègue-Godet; Youssef Ben Salem; Laëtitia Fabre; Marie Demartin; Patrick A D Grimont; Ridha Mzoughi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.

Authors:  C Hal Jones; Alexey Ruzin; Margareta Tuckman; Melissa A Visalli; Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.